81 related articles for article (PubMed ID: 3274806)
1. Transplantation tolerance following conditioning with C1q-affinity anti-Thy-1 monoclonal antibodies.
Thierfelder S; Kummer U; Schuh R
Transplant Proc; 1987 Feb; 19(1 Pt 1):459-61. PubMed ID: 3274806
[No Abstract] [Full Text] [Related]
2. Immunosuppression induced by monoclonal anti-Thy-1,2 antibodies, cyclosporine A, and lentil lectin in mice.
Hilgert I; Stoyanov S; Kristofová H
Transplant Proc; 1987 Feb; 19(1 Pt 2):1269. PubMed ID: 3274316
[No Abstract] [Full Text] [Related]
3. Humoral tolerance in mixed xenogeneic chimeras prepared by a nonmyeloablative conditioning regimen.
Aksentijevich I; Sharabi Y; Sundt TM; Sachs DH; Sykes M
Transplant Proc; 1991 Feb; 23(1 Pt 1):880-2. PubMed ID: 1990712
[No Abstract] [Full Text] [Related]
4. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
5. Anti-Thy-1 in bone marrow transplantation.
Thierfelder S; Kummer U; Hoffmann-Fezer G
Immunol Ser; 1989; 45():531-72. PubMed ID: 2577328
[No Abstract] [Full Text] [Related]
6. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
[TBL] [Abstract][Full Text] [Related]
7. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
8. Adaptive phenomena in bone marrow transplantation.
Goujet-Zalc C; Ilbery PL
Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
[No Abstract] [Full Text] [Related]
9. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
Ito H; Takeuchi Y; Shaffer J; Sykes M
Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
[TBL] [Abstract][Full Text] [Related]
10. Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kwon CH; Noh JH; Kim SJ
Immunol Lett; 2006 Feb; 102(2):215-21. PubMed ID: 16260045
[TBL] [Abstract][Full Text] [Related]
11. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance.
Cobbold SP; Martin G; Qin S; Waldmann H
Nature; 1986 Sep 11-17; 323(6084):164-6. PubMed ID: 3528866
[TBL] [Abstract][Full Text] [Related]
13. Xenogeneic (rat to mouse) skin tolerance induced by monoclonal antibodies, xenogeneic cells, and cyclophosphamide.
Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K; Nomoto K
Transplant Proc; 1995 Feb; 27(1):315-6. PubMed ID: 7879018
[No Abstract] [Full Text] [Related]
14. Antilymphocytic antibodies and marrow transplantation. XIV. Antibody-induced suppression of graft-versus-host disease in C3-decomplemented mice differentiates two T-cell-depletion pathways.
Thierfelder S; Mysliwietz J; Hoffmann-Fezer G; Kummer U
Blood; 1991 May; 77(10):2285-91. PubMed ID: 2029584
[TBL] [Abstract][Full Text] [Related]
15. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R
J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259
[TBL] [Abstract][Full Text] [Related]
16. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
[TBL] [Abstract][Full Text] [Related]
17. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
Chen Z; Cobbold S; Waldmann H; Metcalfe S
Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
[No Abstract] [Full Text] [Related]
18. Antilymphocytic antibodies and marrow transplantation. VIII. Recipient conditioning with Clq-affine monoclonal anti-pan T antibodies prevents GVHD in homozygous fully mismatched mice.
Thierfelder S; Kummer U; Schuh R; Mysliwietz J
Blood; 1986 Oct; 68(4):818-24. PubMed ID: 2875752
[TBL] [Abstract][Full Text] [Related]
19. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
Rodt H; Therfelder S; Eulitz M
Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
[No Abstract] [Full Text] [Related]
20. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.
Jeyarajah DR; Schmeisser FS; Kadakia RA; Thistlethwaite JR
Transplant Proc; 1994 Jun; 26(3):1201-2. PubMed ID: 8029886
[No Abstract] [Full Text] [Related]
[Next] [New Search]
